Risk of birth defects associated with maternal pregestational diabetes

European Journal of Epidemiology

Volumn 29, Issue 6, 2014, Pages 411-418

  Vinceti, Marco ^a   Malagoli, Carlotta ^a   Rothman, Kenneth J ^b,c   Rodolfi, Rossella ^d   Astolfi, Gianni ^e   Calzolari, Elisa ^e   Puccini, Aurora ^f   Bertolotti, Marco ^a   Lunt, Mark ^g   Paterlini, Luisa ^d   Martini, Mariella ^h   Nicolini, Fausto ^d  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b RTI HEALTH SOLUTIONS   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d PATHOLOGY UNIT   (Italy)

^e UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^f Drug Policy Service   (Italy)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

^h Local Health Unit   (Italy)

Author keywords

Cohort study; Congenital abnormalities; Diabetes mellitus; Pregnancy outcome; Risk assessment

Indexed keywords

ADULT; ARTICLE; BIRTH DEFECT; CARDIOVASCULAR DISEASE; CHROMOSOME ABERRATION; COHORT ANALYSIS; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; FEMALE; FETUS RISK; HOSPITAL DISCHARGE; HUMAN; MATERNAL AGE; MATERNAL DIABETES MELLITUS; MUSCULOSKELETAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PREGNANCY OUTCOME; PRESCRIPTION; PREVALENCE; PROGENY; RISK ASSESSMENT; RISK FACTOR; SMOKING; UROGENITAL TRACT DISEASE;

ADULT; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CONGENITAL ABNORMALITIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFANT, NEWBORN; ITALY; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PREVALENCE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84903513520     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-014-9913-4     Document Type: Article

References (68)

1. Allen VM, Armson BA, Wilson RD, Allen VM, Blight C, Gagnon A, Johnson JA, Langlois S, Summers A, Wyatt P, Farine D, Armson BA, Crane J, Delisle MF, Keenan-Lindsay L, Morin V, Schneider CE, Van Aerde J. Society of O, Gynecologists of C. Teratogenicity associated with pre-existing and gestational diabetes. J Obstet Gynaecol Can. 2007;29:927-44.
2. Zabihi S, Loeken MR. Understanding diabetic teratogenesis: where are we now and where are we going? Birth Defects Res A Clin Mol Teratol. 2010;88:779-90.
3. Kitzmiller JL, Wallerstein R, Correa A, Kwan S. Preconception care for women with diabetes and prevention of major congenital malformations. Birth Defects Res A Clin Mol Teratol. 2010;88:791-803.
4. Reece EA. Diabetes-induced birth defects: what do we know? What can we do? Curr Diab Rep. 2012;12:24-32.
5. Negrato CA, Mattar R, Gomes MB. Adverse pregnancy outcomes in women with diabetes. Diabetol Metab Syndr. 2012;4:41.
6. Sharpe PB, Chan A, Haan EA, Hiller JE. Maternal diabetes and congenital anomalies in South Australia 1986-2000: a population-based cohort study. Birth Defects Res A Clin Mol Teratol. 2005;73:605-11. (Pubitemid 41428678)
7. Lapolla A, Dalfra MG, Di Cianni G, Bonomo M, Parretti E, Mello G. A multicenter Italian study on pregnancy outcome in women with diabetes. Nutr Metab Cardiovasc Dis. 2008;18:291-7.
8. Balsells M, Garcia-Patterson A, Gich I, Corcoy R. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2009;94:4284-91.
9. Eidem I, Stene LC, Henriksen T, Hanssen KF, Vangen S, Vollset SE, Joner G. Congenital anomalies in newborns of women with type 1 diabetes: nationwide population-based study in Norway, 1999-2004. Acta Obstet Gynecol Scand. 2010;89:1403-11.
10. Banhidy F, Acs N, Puho EH, Czeizel AE. Congenital abnormalities in the offspring of pregnant women with type 1, type 2 and gestational diabetes mellitus: a population-based case-control study. Congenit Anom (Kyoto). 2010;50:115-21.
11. Beyerlein A, von Kries R, Hummel M, Lack N, Schiessl B, Giani G, Icks A. Improvement in pregnancy-related outcomes in the offspring of diabetic mothers in Bavaria, Germany, during 1987-2007. Diabet Med. 2010;27:1379-84.
12. Murphy HR, Steel SA, Roland JM, Morris D, Ball V, Campbell PJ, Temple RC. East Anglia study group for improving pregnancy outcomes in women with D. Obstetric and perinatal outcomes in pregnancies complicated by type 1 and type 2 diabetes: influences of glycaemic control, obesity and social disadvantage. Diabet Med. 2011;28:1060-7.
13. Bell R, Glinianaia SV, Tennant PW, Bilous RW, Rankin J. Periconception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia. 2012;55:936-47.
14. Al-Agha R, Firth RG, Byrne M, Murray S, Daly S, Foley M, Smith SC, Kinsley BT. Outcome of pregnancy in type 1 diabetes mellitus (T1DMP): results from combined diabetes-obstetrical clinics in Dublin in three university teaching hospitals (1995-2006). Ir J Med Sci. 2012;181:105-9.
15. Garne E, Loane M, Dolk H, Barisic I, Addor MC, Arriola L, Bakker M, Calzolari E, Matias Dias C, Doray B, Gatt M, Melve KK, Nelen V, O'Mahony M, Pierini A, Randrianaivo-Ranjatoelina H, Rankin J, Rissmann A, Tucker D, Verellun-Dumoulin C, Wiesel A. Spectrum of congenital anomalies in pregnancies with pregestational diabetes. Birth Defects Res A Clin Mol Teratol. 2012;94:134-40.
16. Correa A, Gilboa SM, Botto LD, Moore CA, Hobbs CA, Cleves MA, Riehle-Colarusso TJ, Waller DK, Reece EA. Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects. Am J Obstet Gynecol. 2012;206:218.e1-13.
17. Fung A, Manlhiot C, Naik S, Rosenberg H, Smythe J, Lougheed J, Mondal T, Chitayat D, McCrindle BW, Mital S. Impact of prenatal risk factors on congenital heart disease in the current era. J Am Heart Assoc. 2013;2:e000064.
18. Liu S, Joseph KS, Lisonkova S, Rouleau J, Van den Hof M, Sauve R, Kramer MS, Canadian Perinatal Surveillance S. Association between maternal chronic conditions and congenital heart defects: a population-based cohort study. Circulation. 2013;128:583-9.
19. Csaky-Szunyogh M, Vereczkey A, Kosa Z, Gerencser B, Czeizel AE. Risk factors in the origin of congenital left-ventricular outflow-tract obstruction defects of the heart: a population-based case-control study. Pediatr Cardiol.2014;35:108-20.
20. Newham JJ, Glinianaia SV, Tennant PW, Rankin J, Bell R. Improved antenatal detection of congenital anomalies in women with pre-gestational diabetes: population-based cohort study. Diabet Med. 2013;30:1442-8.
21. Feig DS, Hwee J, Shah BR, Booth GL, Bierman AS, Lipscombe LL. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996-2010. Diabetes Care. 2014. doi:10.2337/dc13-2717.
22. McCarter RJ, Kessler II, Comstock GW. Is diabetes mellitus a teratogen or a coteratogen? Am J Epidemiol. 1987;125:195-205. (Pubitemid 17007969)
23. Moore LL, Singer MR, Bradlee ML, Rothman KJ, Milunsky A. A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiology. 2000;11:689-94.
24. McCance DR. Pregnancy and diabetes. Best Pract Res Clin Endocrinol Metab. 2011;25:945-58.
25. Botta RM. Congenital malformations in infants of 517 pregestational diabetic mothers. Ann Ist Super Sanita. 1997;33:307-11. (Pubitemid 128520115)
26. Ballotari P, Chiatamone Ranieri S, Vicentini M, Caroli S, Gardini A, Rodolfi R, Crucco R, Greci M, Manicardi V, Giorgi Rossi P. Building a population-based diabetes register: an Italian experience. Diabetes Res Clin Pract. 2014;103:79-87.
27. Boyd PA, Haeusler M, Barisic I, Loane M, Garne E, Dolk H. Paper 1: the EUROCAT network - organization and processes. Birth Defects Res A Clin Mol Teratol. 2011;91(Suppl 1):S2-15.
28. Boulot P, Chabbert-Buffet N, d'Ercole C, Floriot M, Fontaine P, Fournier A, Gillet JY, Gin H, Grandperret-Vauthier S, Geudj AM, Guionnet B, Hauguel-de-Mouzon S, Hieronimus S, Hoffet M, Jullien D, Lamotte MF, Lejeune V, Lepercq J, Lorenzi F, Mares P, Miton A, Penfornis A, Pfister B, Renard E, Rodier M, Roth P, Sery GA, Timsit J, Valat AS, Vambergue A, Verier-Mine O, Diabetes, Pregnancy Group F. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care. 2003;26:2990-3. (Pubitemid 37339488)
29. Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, Cleves MA, Riehle-Colarusso TJ, Waller DK, Reece EA. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;199:237.e1-9.
30. Dunne FP, Avalos G, Durkan M, Mitchell Y, Gallacher T, Keenan M, Hogan M, Carmody LA, Gaffney G, collaborators AD. ATLANTIC DIP: pregnancy outcomes for women with type 1 and type 2 diabetes. Ir Med J. 2012;105:6-9.
31. McElvy SS, Miodovnik M, Rosenn B, Khoury JC, Siddiqi T, Dignan PS, Tsang RC. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med. 2000;9:14-20. (Pubitemid 30176207)
32. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328:915.
33. Temple RC, Aldridge VJ, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care. 2006;29:1744-9. (Pubitemid 44156624)
34. Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: A large, population-based study. Diabetes Care. 2009;32:2005-9.
35. Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M, Beck-Nielsen H. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care. 2004;27:2819-23. (Pubitemid 39565043)
36. Temple R, Murphy H. Type 2 diabetes in pregnancy - an increasing problem. Best Pract Res Clin Endocrinol Metab. 2010;24:591-603.
37. Cundy T, Gamble G, Townend K, Henley PG, MacPherson P, Roberts AB. Perinatal mortality in type 2 diabetes mellitus. Diabet Med. 2000;17:33-9. (Pubitemid 30094178)
38. Dunne F, Brydon P, Smith K, Gee H. Pregnancy in women with type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med. 2003;20:734-8. (Pubitemid 41701467)
39. McElduff A, Ross GP, Lagstrom JA, Champion B, Flack JR, Lau SM, Moses RG, Seneratne S, McLean M, Cheung NW. Pregestational diabetes and pregnancy: an Australian experience. Diabetes Care. 2005;28:1260-1. (Pubitemid 40616653)
40. Clausen TD, Mathiesen E, Ekbom P, Hellmuth E, Mandrup-Poulsen T, Damm P. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care. 2005;28:323-8. (Pubitemid 40170934)
41. Roland JM, Murphy HR, Ball V, Northcote-Wright J, Temple RC. The pregnancies of women with type 2 diabetes: poor outcomes but opportunities for improvement. Diabet Med. 2005;22:1774-7. (Pubitemid 43046485)
42. Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, Golightly S, Miller A. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006;333:177.
43. Inkster ME, Fahey TP, Donnan PT, Leese GP, Mires GJ, Murphy DJ. Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC Pregnancy Childbirth. 2006;6:30.
44. Lapolla A, Dalfra MG, Fedele D. Pregnancy complicated by type 2 diabetes: an emerging problem. Diabetes Res Clin Pract. 2008;80:2-7.
45. Murphy HR, Roland JM, Skinner TC, Simmons D, Gurnell E, Morrish NJ, Soo SC, Kelly S, Lim B, Randall J, Thompsett S, Temple RC. Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care. 2010;33:2514-20.
46. Waller DK, Shaw GM, Rasmussen SA, Hobbs CA, Canfield MA, Siega-Riz AM, Gallaway MS, Correa A, National Birth Defects Prevention S. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med. 2007;161:745-50. (Pubitemid 47236440)
47. Dennedy MC, Avalos G, O'Reilly MW, O'Sullivan EP, Gaffney G, Dunne F. ATLANTIC-DIP: raised maternal body mass index (BMI) adversely affects maternal and fetal outcomes in glucose-tolerant women according to International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. J Clin Endocrinol Metab. 2012;97:E608-12.
48. Block SR, Watkins SM, Salemi JL, Rutkowski R, Tanner JP, Correia JA, Kirby RS. Maternal pre-pregnancy body mass index and risk of selected birth defects: evidence of a dose-response relationship. Paediatr Perinat Epidemiol. 2013;27:521-31.
49. Ekpebegh CO, Coetzee EJ, van der Merwe L, Levitt NS. A 10-year retrospective analysis of pregnancy outcome in pregestational type 2 diabetes: comparison of insulin and oral glucose-lowering agents. Diabet Med. 2007;24:253-8.
50. Martinez-Frias ML. Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet. 1994;51:108-13. (Pubitemid 24155223)
51. Ewart-Toland A, Yankowitz J, Winder A, Imagire R, Cox VA, Aylsworth AS, Golabi M. Oculoauriculovertebral abnormalities in children of diabetic mothers. Am J Med Genet. 2000;90:303-9. (Pubitemid 30084256)
52. Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev. 2001;61:85-95. (Pubitemid 32149652)
53. Frias JL, Frias JP, Frias PA, Martinez-Frias ML. Infrequently studied congenital anomalies as clues to the diagnosis of maternal diabetes mellitus. Am J Med Genet A. 2007;143A:2904-9. (Pubitemid 350274803)
54. Lupo PJ, Canfield MA, Chapa C, Lu W, Agopian AJ, Mitchell LE, Shaw GM, Waller DK, Olshan AF, Finnell RH, Zhu H. Diabetes and obesity-related genes and the risk of neural tube defects in the national birth defects prevention study. Am J Epidemiol. 2012;176:1101-9.
55. Giampietro PF, Raggio CL, Blank RD, McCarty C, Broeckel U, Pickart MA. Clinical, genetic and environmental factors associated with congenital vertebral malformations. Mol Syndromol. 2013;4:94-105.
56. Chernoff N, Rogers JM. Supernumerary ribs in developmental toxicity bioassays and in human populations: incidence and biological significance. J Toxicol Environ Health B Crit Rev. 2004;7:437-49. (Pubitemid 39487650)
57. Unger E, Kjellen L, Eriksson UJ. Effect of insulin on the altered production of proteoglycans in rib cartilage of experimentally diabetic rats. Arch Biochem Biophys. 1991;285:205-10.
58. Unger E, Eriksson UJ. Regionally disturbed production of cartilage proteoglycans in malformed fetuses from diabetic rats. Diabetologia. 1992;35:517-21.
59. Jiang HJ, Andrews R, Stryer D, Friedman B. Racial/ethnic disparities in potentially preventable readmissions: the case of diabetes. Am J Public Health. 2005;95:1561-7. (Pubitemid 41232949)
60. Verheijen EC, Critchley JA, Whitelaw DC, Tuffnell DJ. Outcomes of pregnancies in women with pre-existing type 1 or type 2 diabetes, in an ethnically mixed population. BJOG. 2005;112:1500-3. (Pubitemid 43961236)
61. Dunne FP, Brydon PA, Proffitt M, Smith T, Gee H, Holder RL. Fetal and maternal outcomes in Indo-Asian compared to Caucasian women with diabetes in pregnancy. QJM. 2000;93:813-8.
62. Chaudhry T, Ghani AM, Mehrali TH, Taylor RS, Brydon PA, Gee H, Barnett AH, Dunne FP. A comparison of foetal and labour outcomes in Caucasian and Afro-Caribbean women with diabetes in pregnancy. Int J Clin Pract. 2004;58:932-6. (Pubitemid 39642615)
63. Hughes R, Rowan J. Perinatal outcomes and macrosomia in a multi-ethnic population of women with type 2 diabetes. Aust N Z J Obstet Gynaecol. 2006;46:552-5. (Pubitemid 44762481)
64. Jonasson JM, Brismar K, Sparen P, Lambe M, Nyren O, Ostenson CG, Ye W. Fertility in women with type 1 diabetes: a population-based cohort study in Sweden. Diabetes Care. 2007;30:2271-6. (Pubitemid 47359030)
65. Bell R, Bailey K, Cresswell T, Hawthorne G, Critchley J, Lewis-Barned N. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG. 2008;115:445-52. (Pubitemid 351225158)
66. Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care. 2007;30:1920-5. (Pubitemid 47036383)
67. Inkster ME, Fahey TP, Donnan PT, Leese GP, Mires GJ, Murphy DJ. The role of modifiable pre-pregnancy risk factors in preventing adverse fetal outcomes among women with type 1 and type 2 diabetes. Acta Obstet Gynecol Scand. 2009;88:1153-7.
68. Parker SE, Yazdy MM, Tinker SC, Mitchell AA, Werler MM. The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida. Am J Obstet Gynecol. 2013;209:239.e1-8.